Search hospitals > New York > Staten Island
Richmond Behavioral Associates
Claim this profileStaten Island, New York 10312
Global Leader in Alzheimer's Disease
Global Leader in Major Depressive Disorder
Conducts research for Depression
Conducts research for Schizophrenia
Conducts research for Autism Spectrum Disorder
105 reported clinical trials
4 medical researchers
Summary
Richmond Behavioral Associates is a medical facility located in Staten Island, New York. This center is recognized for care of Alzheimer's Disease, Major Depressive Disorder, Depression, Schizophrenia, Autism Spectrum Disorder and other specialties. Richmond Behavioral Associates is involved with conducting 105 clinical trials across 66 conditions. There are 4 research doctors associated with this hospital, such as Mark DiBuono, MD, Matt DiBuono, MD, Adam Smith, PhD, and Mark Vincent DiBuono.Area of expertise
1Alzheimer's Disease
Global LeaderApoE
APOE ε4 positive
Aβ1-42 positive
2Major Depressive Disorder
Global LeaderMGH-ATRQ
serotonin
norepinephrine
Top PIs
Mark DiBuono, MDRichmond Behavioral Associates5 years of reported clinical research
Studies Alzheimer's Disease
Studies Dementia
10 reported clinical trials
12 drugs studied
Matt DiBuono, MDRichmond Behavioral Associates3 years of reported clinical research
Studies Autism Spectrum Disorder
Studies Autism
2 reported clinical trials
1 drug studied
Adam Smith, PhDRichmond Behavioral Associates2 years of reported clinical research
Studies Schizophrenia
1 reported clinical trial
1 drug studied
Mark Vincent DiBuonoRichmond Behavioral Associates4 years of reported clinical research
Studies Alzheimer's Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Richmond Behavioral Associates
Alzheimer's Disease
Depression
Mania
Bipolar disorder
Akathisia
Alzheimer's Dementia
Agitation
Cognitive Impairment
Alzheimer's disease
Major Depressive Disorder
KarXT + KarX-EC
for Agitation in Alzheimer's Disease
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.
Recruiting1 award Phase 31 criteria
KarXT
for Alzheimer's-Associated Psychosis
This trial is testing KarXT, a medication, to see if it can prevent psychotic symptoms from returning in people with Alzheimer's Disease. It works by balancing brain chemicals that cause hallucinations and delusions. KarXT has shown positive results in reducing symptoms of schizophrenia.
Recruiting1 award Phase 316 criteria
Buntanetap
for Alzheimer's Disease
The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn about the safety of buntanetap/Posiphen. The main questions it aims to answer are: * Does buntanetap/Posiphen improve cognition as measured by ADAS-Cog13? * Does buntanetap/Posiphen improve function as measured by ADCS-iADL? * What medical issues do participants have, if any, when taking buntanetap/Posiphen? Researchers will compare buntanetap/Posiphen to a placebo (a look-alike substance that contains no drug) to see if buntanetap/Posiphen works to treat early Alzheimer's disease. Participants will: * Take buntanetap/Posiphen or a placebo every day for 18 months * Visit the clinic periodically for checkups, tests, and questionnaires (screening visits, enrollment, month 1, month 3, month 6, month 9, month 12, month 15, month 18), including a volumetric MRI at month 6 and month 18 * Complete pre- and post-clinic visit phone calls
Recruiting1 award Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Richmond Behavioral Associates?
Richmond Behavioral Associates is a medical facility located in Staten Island, New York. This center is recognized for care of Alzheimer's Disease, Major Depressive Disorder, Depression, Schizophrenia, Autism Spectrum Disorder and other specialties. Richmond Behavioral Associates is involved with conducting 105 clinical trials across 66 conditions. There are 4 research doctors associated with this hospital, such as Mark DiBuono, MD, Matt DiBuono, MD, Adam Smith, PhD, and Mark Vincent DiBuono.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.